Sartorius to acquire Novasep’s chromatography process equipment division

by Sartorius Stedim Spain

The life science company Sartorius today announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep.

Read more

New potential treatment for diabetes, with the participation of Mind the Byte

by Mind the Byte

Type 2 diabetes (T2D) is a complex disease caused by the interaction of genetic and environmental factors. It happens when pancreatic islets fail to produce enough insulin, or body target cells do not...

Read more

New biotech plant for the production of insulin, for Beximco Pharma in Dhaka

by Telstar

Beximco Pharma has awarded Telstar a contract to implement the architecture and HVAC system for the new insulin production plant of the Bengali company in Dhaka (Bangladesh). The new plant, which is p...

Read more

Demuestran la acción protectora de una enzima frente a la esteatosis, obesidad y resistencia a la insulina

by Universidad Autónoma de Madrid

Investigadores del CSIC, la UAM y el Instituto de Investigaciones Biomédicas Alberto Sols han demostrado la acción protectora de una enzima frente a la esteatosis, obesidad y resistencia a la insuli...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream